Male pattern baldness follows a predictable biological progression, but the options available to you depend significantly on which stage you're at. Early intervention — before follicle miniaturization becomes permanent — is more effective than trying to reverse what's already set in. Knowing your stage is the most practical first step.
The Growth Complex for Men is designed to support hair health by addressing the nutritional and hormonal factors that amplify androgenic hair loss — particularly during the earlier stages when follicles are compromised but still active. Here's the full picture on stages, mechanisms, and what currently works.
The Norwood Scale: A Practical Guide
The Hamilton-Norwood scale is the standard classification system for male pattern baldness. It maps hair loss progression across seven primary stages:
Type I: No visible recession. Normal juvenile hairline. No treatment needed.
Type II: Slight recession at the temples. Most men in their 20s and 30s reach at least this point; it's at the boundary between normal maturation and early-stage MPB.
Type III: Deeper temple recession or thinning at the crown begins (Type III Vertex). This is the earliest stage where intervention typically becomes worth pursuing.
Type IV: Significant recession at the temples and thinning at the crown, with a band of hair separating them. The band is still present.
Type V: The bridge of hair between the temples and crown narrows. Significant coverage loss across the top of the scalp.
Type VI: The bridge disappears. Temple and crown areas merge into a single area of significant thinning.
Type VII: Only a horseshoe-shaped band of hair remains at the sides and back. The most advanced stage.
The progression through these stages is driven primarily by genetics and DHT — but the rate at which it progresses is influenced by additional factors including nutritional status, overall health, and scalp environment.
The Mechanism: Why DHT Shrinks Follicles
Male pattern baldness is androgenetic alopecia — hair loss caused by the interaction of androgens (primarily DHT) with genetically susceptible follicles.
DHT (dihydrotestosterone) is produced from testosterone by the enzyme 5-alpha reductase. In follicles that are genetically sensitive to DHT, this hormone binds to androgen receptors and triggers follicular miniaturization — a process where the follicle gradually shrinks over successive cycles, producing progressively thinner and shorter hairs until it may become dormant.
Not all follicles are equally sensitive. The follicles at the crown and temples carry more androgen receptors in most men with MPB — which explains the characteristic pattern. The follicles at the sides and back of the scalp (the "safe zone") are typically resistant, which is why they remain even at advanced stages and why they're used as donor sites for hair transplants.
What Works at Each Stage
The effectiveness of various treatments varies significantly with stage:
Types I–II (Early/Minimal):
At this stage, the goal is preservation — slowing or halting the progression before significant miniaturization occurs. Options with evidence:
- Nutritional support: Addressing nutritional factors (zinc, selenium, iron) that amplify androgenic loss. Won't reverse the genetic predisposition, but reduces the rate of progression when deficiencies are present.
- Finasteride (oral, prescription): The most effective pharmacological intervention for early-stage MPB. Inhibits 5-alpha reductase, reducing DHT production by approximately 70%, with clinical trials demonstrating hair count improvements in the majority of men (Kaufman et al., J Am Acad Dermatol, 1998). Most effective when started early. Requires a prescription; speak with a dermatologist before starting.
- Minoxidil (topical or oral): FDA-approved for hair loss. Works by improving scalp blood flow and may extend the anagen phase. Most effective in earlier stages.
Types III–IV (Active Progression):
The priority shifts from pure preservation to slowing active progression and maximizing the function of follicles still in the miniaturization process.
- The same interventions apply, with increased urgency. Combination therapy (finasteride + minoxidil) has better evidence than either alone.
- Derma rolling at the scalp has emerging evidence for stimulating dormant follicles via micro-injury signaling. Worth considering as an adjunct.
- Nutritional support remains relevant — zinc deficiency in particular has been documented to correlate with more aggressive androgenic loss.
Types V–VII (Advanced):
At these stages, follicle miniaturization is more advanced and many follicles may be permanently dormant. Medical interventions still help preserve remaining hair, but the realistic goal changes:
- Hair transplant (FUE or FUT) is the most effective option for restoring coverage at these stages. It relocates DHT-resistant follicles from the safe zone to thinning areas.
- Medical therapy (finasteride, minoxidil) helps stabilize the donor and remaining hair.
- Nutritional support for scalp health, and styling strategies that maximize the appearance of existing hair, become primary.
The Nutritional Amplifiers of MPB
While DHT is the primary driver, several nutritional factors significantly affect how quickly and severely pattern baldness progresses:
Zinc: Lower zinc levels are consistently documented in men with androgenetic alopecia compared to controls. Zinc has a partial inhibitory effect on 5-alpha reductase and is required for follicle cycling.
Selenium: Supports thyroid function (thyroid dysfunction amplifies hair loss) and has antioxidant effects at the follicle level.
Vitamin D: Deficiency is significantly more common in men with hair loss than in the general male population. Vitamin D receptors are expressed in hair follicles, and their activation is associated with hair cycling.
Protein: Hair is keratin. Insufficient protein intake directly limits the raw material available for hair production, regardless of follicle health.
A Note on Timeline
Whatever intervention you pursue, the timeline for visible results is long. Hair cycles take 3–6 months to reflect changes in follicle health. Finasteride typically shows results at 6–12 months. Nutritional supplementation follows the same timeline as described throughout the Growth Complex cluster. Evaluating any intervention before the 6-month mark doesn't give accurate data.
Your Stage Determines Your Strategy
The stage of male pattern baldness you're at determines which interventions are realistic and what you can reasonably expect from them. Early intervention — while the follicles are compromised but still active — is consistently more effective than addressing advanced loss. Nutritional support, pharmaceutical DHT management, and scalp health maintenance form the strongest multi-factor approach. At advanced stages, the honest answer shifts toward hair transplant as the most effective restoration option, with medical therapy and nutrition supporting what remains.
Frequently Asked Questions
Q: At what age does male pattern baldness usually start?
Male pattern baldness can begin as early as the late teens or early 20s in men with strong genetic predisposition, though it's more common for noticeable changes to appear in the mid-to-late 20s. By age 50, approximately 50% of men show significant MPB; by age 70, approximately 80%. The earlier it begins, the more significant the ultimate loss tends to be — which is also why early intervention makes the greatest difference.
Q: Is male pattern baldness from my mom's side or my dad's side?
Both. The AR gene (androgen receptor gene) relevant to MPB is located on the X chromosome — meaning the maternal line has traditionally been emphasized. But the genetics are polygenic, meaning multiple genes across multiple chromosomes contribute. Looking at both maternal and paternal family history gives a more accurate predictive picture than either side alone. If both parents' families show significant hair loss, your risk is higher.
Q: Can MPB be reversed at an early stage?
Some regrowth is possible at Types II–III with consistent use of finasteride and/or minoxidil, especially in younger men who start early. These medications can also thicken existing miniaturized hairs. "Reversal" is a strong word — what's more accurate is that early intervention can restore functional density to follicles that are miniaturized but not dormant. Once follicles are fully dormant, pharmaceutical regrowth is limited.
Q: Does wearing hats cause or worsen male pattern baldness?
No — this is a persistent myth. Male pattern baldness is caused by DHT acting on genetically susceptible follicles, not by reduced scalp circulation from hat-wearing. A hat worn for normal periods doesn't meaningfully reduce scalp blood flow. Extremely tight hats worn for extended periods every day could theoretically cause traction alopecia, but this would produce a different and distinct pattern from androgenetic alopecia.
